Monitoring of transtubular potassium gradient in the diuretic management of patients with cirrhosis and ascites

Liver

Volumn 22, Issue 5, 2002, Pages 426-432

  Lim, Young Suk ^a   Han, Jin Suk ^a   Kim, Kyung Ah ^a   Yoon, Jung Hwan ^a   Kim, Chung Yong ^a   Lee, Hyo Suk ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Aldosterone; Cirrhotic ascites; Gradient; Spironolactone; Transtubular potassium

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; DIURETIC AGENT; FUROSEMIDE; POTASSIUM ION; SPIRONOLACTONE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; ASCITES; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIURESIS; DIURETIC THERAPY; DOSE RESPONSE; FEMALE; HORMONE ACTION; HUMAN; KIDNEY TUBULE; LIVER CIRRHOSIS; MALE; PATIENT MONITORING; POTASSIUM EXCRETION; POTASSIUM TRANSPORT; SIDE EFFECT;

ALDOSTERONE ANTAGONISTS; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; FIBROSIS; FUROSEMIDE; HUMANS; KIDNEY TUBULES; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; POTASSIUM; SPIRONOLACTONE;

EID: 0036810147     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2001.01693.x     Document Type: Article

References (23)

1. GINES P, QUINTERO E, ARROYO V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122-8.
2. WILKINSON S P, JOWETT T P, SLATER J D, ARROYO V, MOODIE H, WILLIAMS R. Renal sodium retention in cirrhosis: relation to aldosterone and nephron site. Clin Sci 1979; 56: 169-77.
3. BOSCH J, ARROYO V, BETRIU A, et al. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980; 78: 92-9.
4. BERNARDI M, SERVADEI D, TREVISANI F, RUSTICALI A G, GASBARRINI G. Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites. Digestion 1985; 31: 189-93.
5. ROSOFF L Jr, ZIA P, REYNOLDS T, HORTON R. Studies of renin and aldosterone in cirrhotic patients with ascites. Gastroenterology 1975; 69: 698-705.
6. GIUSEFFI J, WERK E E Jr, LARSON P V, SCHIFF L, ELLIOTT D W. Effect of bilateral adrenalectomy in a patient with massive ascites and postnecrotic cirrhosis. N Engl J Med 1957; 257: 796-803.
7. PEREZ-AYUSO R M, ARROYO V, PLANAS R, et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Gastroenterology 1983; 84: 961-8.
8. FOGEL M R, SAWHNEY V K, NEAL E A, MILLER R G, KNAUER C M, GREGORY P B. Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol 1981; 3: 73-80.
9. BOYER T D, WARNOCK D G. Use of diuretics in the treatment of cirrhotic ascites. Gastroenterology 1983; 84: 1051-5.
10. SHERLOCK S, SENEWIRATNE B, SCOTT A, WALKER J G. Complications of diuretic therapy in hepatic cirrhosis. Lancet 1966; 1: 1049-52.
11. EGGERT R C. Spironolactone diuresis in patients with cirrhosis and ascites. BMJ 1970; 4: 401-3.
12. RUNYON B A. Treatment of patients with cirrhosis and ascites. Semin Liver Dis 1997; 17: 249-60.
13. WARNER L C, CAMPBELL P J, MORALI G A, LOGAN A G, SKORECKI K L, BLENDIS L M. The response of atrial natriuretic factor and sodium excretion to dietary sodium challenges in patients with chronic liver disease. Hepatology 1990; 12: 460-6.
14. WEST M L, MARSDEN P A, RICHARDSON R M A, ZETTLE R M, HALPERIN M L. New clinical approach to evaluate disorders of potassium excretion. Miner Electrolyte Metab 1986; 12: 234-8.
15. WEST M L, BENDZ O, CHEN C B, et al. Development of a test to evaluate the transtubular potassium concentration gradient in the cortical collecting duct in vivo. Miner Electrolyte Metab 1986; 12: 226-33.
16. RUNYON B A, MONTANO A A, AKRIVIADIS E A, ANTILLON M R, IRVING M A, MCHUTCHISON J G. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 1992; 117: 215-20.
17. GATTA A, ANGELI P, CAREGARO L, MENON F, SACERDOTI D, MERKEL C. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients. Hepatology 1991; 14: 231-6.
18. RUNYON B A, HECK M. Utility of 24-hour urine sodium collections and urine Na/K ratios in the management of patients with cirrhosis and ascites. Hepatology 1996; 24: 571A (Abstract).
19. KAMEL K S, ETHIER J H, RICHARDSON R M, BEAR R A, HALPERIN M L. Urine electrolytes and osmolality: when and how to use them. Am J Nephrol 1990; 10: 89-102.
20. RODRIGUEZ-SORIANO J, UBETAGOYENA M, VALLO A. Transtubular potassium concentration gradient: a useful test to estimate renal aldosterone bio-activity in infants and children. Pediatr Nephrol 1990; 4: 105-10.
21. ZETTLE R M, WEST M L, JOSSE R G, RICHARDSON R M, MARSDEN P A, HALPERIN M L. Renal potassium handling during states of low aldosterone bio-activity: a method to differentiate renal and non-renal causes. Am J Nephrol 1987; 7: 360-6.
22. BERNARDI M, MARCO C D, TREVISANI F, et al. Renal sodium retention during upright posture in preascitic cirrhosis. Gastroenterology 1993; 105: 188-93.
23. RING-LARSEN H, HENRIKSEN JH, WILKEN C, CLAUSEN J, PALS H, CHRISTENSEN N J. Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. BMJ 1986; 292: 1351-3.